Discovery of gefitinib-1,2,3-triazole derivatives against lung cancer via inducing apoptosis and inhibiting the colony formation
Article in Scientific Reports (April 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Synthesis and In Vitro Antitumor Activity Evaluation of Gefitinib-1,2,3-Triazole Derivatives
Article in Molecules (February 2024)
Synthesis of novel pyrido[2,3-d]pyrimidine-thiazolidine-1,2,3-triazoles: Potent EGFR targeting anticancer agents
Article in Journal of Molecular Structure (December 2023)